under reduced pressure. Purification was performed by a silica gel column eluted with
1
hexane/EtOAc to give desire product. Reaction conversion and d.r. were determined by H NMR
spectroscopy.
N-((cis)-2-Butyl-1,2,3,4-tetrahydroquinolin-3-yl)-4-methylbenzenesulfonamide
:
78%
= 0.60 (petroleum ether/EtOAc 5:1). H NMR (400
MHz, CDCl ) δ = 7.72 (d, J = 7.5, 2H), 7.27 (d, J = 8.3, 2H), 6.98 (t, J = 7.4,
o
1
yield, 62% ee, white solid, mp 164-166 C, R
f
NHTs
3
1
H), 6.77 (d, J = 7.3, 1H), 6.63 (t, J = 7.1, 1H), 6.47 (d, J = 7.8, 1H), 4.92 (d,
N
H
J = 9.0, 1H), 3.72 (d, J = 7.6, 1H), 3.62 (s, 1H), 3.18 (d, J = 6.2, 1H), 2.86
13
(
d, J = 16.5, 1H), 2.57 (d, J = 16.5, 1H), 2.42 (s, 3H), 1.06-1.45 (m, 6H), 0.83 (t, J = 5.5, 3H); C
NMR (100 MHz, CDCl ) δ = 143.7, 143.4, 138.9, 130.6, 129.8, 127.4, 127.2, 118.6, 118.0, 114.4,
3
+
5
3
5.0, 48.5, 34.5, 31.8, 27.8, 22.8, 21.7, 14.1; HRMS Calculated for C H N O S [M+H]
20 27 2 2
o
59.1793, found 359.1790; Chirapak AD-H column, 254 nm, 30 C, n-hexane/i-propanol = 80/20,
flow = 0.9 mL/min, retention time 11.6 min and 13.3 min (major).
N-((trans)-2-Butyl-1,2,3,4-tetrahydroquinolin-3-yl)-4-methylbenzenesulfonamide : 11%
1
yield, colorless oil, R
f
= 0.55 (petroleum ether/EtOAc 5:1). H NMR (400 MHz, CDCl
3
) δ = 7.72
(
d, J = 8.2, 2H), 7.28 (d, J = 8.1, 2H), 6.98 (t, J = 7.6, 1H), 6.78 (d, J = 7.4,
H), 6.61 (td, J = 7.4, 0.8, 1H), 6.47 (d, J = 7.9, 1H), 4.90 (d, J = 9.1, 1H),
3.95 (s, 1H), 3.63 (td, J = 8.0, 3.6, 1H), 3.05–2.94 (m, 1H), 2.82 (dd, J =
NHTs
1
N
H
13
1
6.7, 4.5, 1H), 2.52–2.44 (m, 1H), 2.43 (s, 3H), 1.38–1.13 (m, 6H), 0.84 (t, J = 7.0, 3H); C NMR
(
100 MHz, CDCl ) δ = 143.3, 142.0, 138.6, 130.3, 129.7, 127.5, 126.9, 117.7, 116.5, 114.3, 55.1,
3
+
4
9.0, 33.8, 29.7, 27.7, 22.4, 21.5, 13.9; HRMS Calculated for C H N O S [M+H] 359.1793,
20
27
2
2
found 359.1793.
N-(2-Butyl-1,2,3,4-tetrahydroquinolin-3-yl)benzamide: 90% yield, 84% ee, d.r. 8:1,
1
colorless oil. H NMR (400 MHz, CDCl
3
) δ = 7.69 (d, J = 7.8, 2H), 7.41 (dt, J = 15.1, 7.3, 3H),
7
1
.01 (dd, J = 18.1, 7.6, 2H), 6.76-6.51 (m, 3H), 4.67-4.44 (m, 1H), 3.77 (s,
H), 3.44-3.24 (m, 1H), 3.20-3.03 (m, 1H), 2.94 (d, J = 16.9, 0.89H), 2.82
(
d, J = 16.8, 0.11H), 1.73-1.56 (m, 1H), 1.53-1.28 (m, 5H), 0.92 (t, J = 6.9,
1
3
3
1
3
H); C NMR (100 MHz, CDCl ) δ = 167.3, 143.9, 140.8, 139.5, 134.8, 131.3, 131.3, 130.6,
3
30.5, 128.5, 128.4, 127.3, 127.0, 127.0, 126.9, 119.3, 118.7, 117.8, 117.7, 114.5, 54.3, 45.3, 44.8,
9.1, 34.0, 33.8, 32.3, 28.9, 28.1, 27.9, 22.7, 22.6, 14.0, 13.9; HRMS Calculated for C H N O
2
0
25
2
+
o
[
M+H] 309.1967, found 309.1965; Chirapak AD-H column, 254 nm, 30 C, n-hexane/i-propanol
=
70/30, flow = 0.7 mL/min, retention time 7.3 min (major) and 8.5 min.
Phenyl 2-butyl-1,2,3,4-tetrahydroquinolin-3-ylcarbamate: 97% yield, 63% ee, d.r. 8:1,
1
colorless oil. H NMR (400 MHz, CDCl
3
) δ = 7.40-7.28 (m, 2H), 7.22-7.07 (m, 3H), 7.06-6.97 (m,
H), 6.77-6.65 (m, 1H), 6.53 (t, J = 9.0, 1H), 5.45 (d, J = 9.0, 0.89H), 5.20
d, J = 8.9, 0.11H), 4.30-4.17 (m, 1H), 3.70 (s, 1H), 3.34 (t, J = 6.0, 0.89H),
.25 (d, J = 2.9, 0.11H), 3.18-2.99 (m, 1H), 2.97-2.75 (m, 1H), 1.76-1.57
2
(
3
1
3
(
m, 1H), 1.55-1.29 (m, 5H), 0.99-0.87 (m, 3H); C NMR (100 MHz, CDCl ) δ = 154.6, 151.1,
3
1
1
2
51.1, 143.8, 130.6, 130.5, 129.4, 129.2, 127.4, 127.2, 126.3, 125.5, 125.1, 121.7, 121.6, 121.5,
18.7, 118.5, 117.7, 114.4, 114.3, 54.2, 46.8, 46.4, 34.8, 34.2, 33.9, 32.1, 29.2, 28.0, 27.8, 22.7,
+
2.6, 14.0, 14.0; HRMS Calculated for C H N O [M+H] 325.1916, found 325.1920; HPLC:
2
0
25
2
2
o
Chiracel OD-H column, 254 nm, 30 C, n-hexane/i-propanol = 95/5, flow = 0.8 mL/min, retention
time 25.4 min (major) and 28.0 min.
S4